DE69918046D1 - Neue basische Derivate von Benz(e)isoindol-1-onen und Pyrrolo(3,4-c)chinolin-1-onen mit 5-HT3-antagonistischer Aktivität, ihre Herstellung und ihre therapeutische Verwendung - Google Patents

Neue basische Derivate von Benz(e)isoindol-1-onen und Pyrrolo(3,4-c)chinolin-1-onen mit 5-HT3-antagonistischer Aktivität, ihre Herstellung und ihre therapeutische Verwendung

Info

Publication number
DE69918046D1
DE69918046D1 DE69918046T DE69918046T DE69918046D1 DE 69918046 D1 DE69918046 D1 DE 69918046D1 DE 69918046 T DE69918046 T DE 69918046T DE 69918046 T DE69918046 T DE 69918046T DE 69918046 D1 DE69918046 D1 DE 69918046D1
Authority
DE
Germany
Prior art keywords
ones
group
isoindol
benz
quinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918046T
Other languages
English (en)
Other versions
DE69918046T2 (de
Inventor
Francesco Makovec
Andrea Cappelli
Maurizio Anzini
Salvatore Vomero
Lucio Claudio Rovati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Publication of DE69918046D1 publication Critical patent/DE69918046D1/de
Application granted granted Critical
Publication of DE69918046T2 publication Critical patent/DE69918046T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DE69918046T 1998-10-13 1999-10-12 Neue basische Derivate von Benz(e)isoindol-1-onen und Pyrrolo(3,4-c)chinolin-1-onen mit 5-HT3-antagonistischer Aktivität, ihre Herstellung und ihre therapeutische Verwendung Expired - Fee Related DE69918046T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITTO980871 1998-10-13
IT1998TO000871A IT1303123B1 (it) 1998-10-13 1998-10-13 Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed

Publications (2)

Publication Number Publication Date
DE69918046D1 true DE69918046D1 (de) 2004-07-22
DE69918046T2 DE69918046T2 (de) 2005-07-14

Family

ID=11417108

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918046T Expired - Fee Related DE69918046T2 (de) 1998-10-13 1999-10-12 Neue basische Derivate von Benz(e)isoindol-1-onen und Pyrrolo(3,4-c)chinolin-1-onen mit 5-HT3-antagonistischer Aktivität, ihre Herstellung und ihre therapeutische Verwendung

Country Status (10)

Country Link
US (2) US6323216B1 (de)
EP (1) EP1018512B1 (de)
JP (1) JP2000119270A (de)
AT (1) ATE269329T1 (de)
AU (1) AU754739B2 (de)
CA (1) CA2285817C (de)
DE (1) DE69918046T2 (de)
ES (1) ES2218930T3 (de)
IT (1) IT1303123B1 (de)
PT (1) PT1018512E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8656101A (en) * 2000-08-21 2002-03-04 Univ Georgetown 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
EP1620435A1 (de) * 2003-04-21 2006-02-01 Pfizer Inc. Imidazopyridine mit aktivität als 5-ht4 rezeptor agonist und 5ht3 rezeptor antagonist
SE0400970D0 (sv) 2004-04-14 2004-04-14 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
US8697722B2 (en) * 2007-11-02 2014-04-15 Sri International Nicotinic acetylcholine receptor modulators
PL2326645T3 (pl) * 2008-07-29 2013-04-30 Acraf Związek o aktywności serotoninergicznej, sposób jego otrzymywania i zawierająca go kompozycja farmaceutyczna
JP5840143B2 (ja) 2010-01-11 2016-01-06 アストライア セラピューティクス, エルエルシーAstraea Therapeutics, Llc ニコチン性アセチルコリン受容体モジュレーター
WO2020097389A1 (en) * 2018-11-09 2020-05-14 Vivace Therapeutics, Inc. Bicyclic compounds
KR102909464B1 (ko) 2019-04-16 2026-01-09 비바체 테라퓨틱스, 인크. 바이사이클릭 화합물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200413A (en) 1987-01-05 1993-04-06 Beecham Group P.L.C. Indolyl carboxamides useful treating migraine, cluster headache, trigeminal neuralgia or emesis
GB9009542D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Novel compounds
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
JPH06506443A (ja) * 1991-01-09 1994-07-21 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー アザ二環式およびアザ三環式誘導体、その製法および中間体ならびに該化合物含有の医薬組成物
US5260303A (en) 1991-03-07 1993-11-09 G. D. Searle & Co. Imidazopyridines as serotonergic 5-HT3 antagonists
US5280028A (en) 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
IT1265057B1 (it) 1993-08-05 1996-10-28 Dompe Spa Tropil 7-azaindolil-3-carbossiamidi
WO1995009168A1 (en) 1993-09-30 1995-04-06 Tokyo Tanabe Company Limited Indoline compound and 5-ht3 receptor antagonist containing the same as active ingredient
FR2710915B1 (fr) 1993-10-04 1995-11-24 Synthelabo Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
EP0647639A1 (de) 1993-10-11 1995-04-12 Sanofi Heteroarylpiperidinen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammenstellungen
US5399562A (en) 1994-02-04 1995-03-21 G. D. Searle & Co. Indolones useful as serotonergic agents
GB9410441D0 (en) * 1994-05-25 1994-07-13 Erba Carlo Spa Azabicycloakyl derivatives of imidazo (1,5-a) indol-3-one and process for their preparation

Also Published As

Publication number Publication date
US20020042426A1 (en) 2002-04-11
EP1018512B1 (de) 2004-06-16
US6413978B1 (en) 2002-07-02
AU5359799A (en) 2000-04-20
ES2218930T3 (es) 2004-11-16
AU754739B2 (en) 2002-11-21
US6323216B1 (en) 2001-11-27
JP2000119270A (ja) 2000-04-25
CA2285817A1 (en) 2000-04-13
DE69918046T2 (de) 2005-07-14
CA2285817C (en) 2008-12-16
ATE269329T1 (de) 2004-07-15
PT1018512E (pt) 2004-08-31
IT1303123B1 (it) 2000-10-30
EP1018512A1 (de) 2000-07-12
ITTO980871A1 (it) 2000-04-13

Similar Documents

Publication Publication Date Title
ATE219071T1 (de) Tricyclische verbindungen mit bindungsaffinität für melatoninrezeptoren, deren herstellung und verwendung
DK0640592T3 (da) N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister
ATE373656T1 (de) Azaindolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DE69329386D1 (de) Substituierte benzylaminoquinuclidine als substanz p antagonisten
DE69331190D1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
FI931370A0 (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
CA2207784A1 (en) Certain pyrrolopyridine derivatives; novel crf1 specific ligands
DE69019020D1 (de) Tricyclische kondensierte Pyrimidin-Derivate, ihre Herstellung und Verwendung.
DE69918046D1 (de) Neue basische Derivate von Benz(e)isoindol-1-onen und Pyrrolo(3,4-c)chinolin-1-onen mit 5-HT3-antagonistischer Aktivität, ihre Herstellung und ihre therapeutische Verwendung
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
ATE109136T1 (de) Substituierte cyclohexene mit zentraler nervensystem-wirkung.
PT96757A (pt) Processo de preparacao de derivados de indolo e de composicoes farmaceuticas
DE69425510D1 (de) 3-substituierte 1-arylindolverbindungen
GR82272B (de)
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
FR2626279B1 (fr) Nouveaux derives de l&#39;indolo(3,2,1-de)(1,4)-oxazino(2,3,4-ij)(1,5) naphthyridine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
DK0746556T3 (da) Tricycliske forbindelser med affinitet for 5-HT1A-receptoren
DE69406763D1 (de) Pyridazinon Derivate, Herstellungsverfahren und Verwendung
ATE108444T1 (de) 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik.
GB2009732A (en) Disubstituted Piperazines

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ROTTAPHARM S.P.A., MILANO, IT

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee